Stockreport

Ionis reports second quarter 2025 financial results and highlights progress on key programs

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF - TRYNGOLZATM delivers $19 million in net product sales in the second quarter 2025 -- Donidalorsen approval in hereditary angioedema (HAE) anticipated next month; Ionis’ [Read more]